Diagnóstico clínico y tratamiento | 12 AGO 13

Actualización en hiponatremia

Un problema clínico común en una rigurosa puesta al día de sus causas, mecanismos, presentaciones clínicas y tratamientos.
Autor/a: Dres. Yeong-Hau H. Lien, Joseph I. Shapiro. The American Journal of Medicine, 120 (8): 653-8. Agosto 2007
INDICE:  1. Desarrollo | 2. Referencias


1. Anderson RJ, Chung HM, Kluge R, Schrier RW. Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med. 1985;102(2):164-168.
2. Tung YR, Lai MC, Lui CC, et al. Tuberculous meningitis in infancy. Pediatr Neurol. 2002;27(4):262-266.
3. Bussmann C, Bast T, Rating D. Hyponatraemia in children with acute CNS disease: SIADH or cerebral salt wasting? Childs Nerv Syst. 2001;17(1-2):58-62; discussion 63.
4. Kockaerts Y, Vanhees S, Knockaert DC, Verhaegen J, Lontie M, Peetermans WE. Imported malaria in the 1990s: a review of 101 patients. Eur J Emerg Med. 2001;8(4):287-290.
5. Sowunmi A. Hyponatraemia in severe falciparum malaria: a clinical study of nineteen comatose African children. Afr J Med Med Sci. 1996;25(1):47-52.
6. Tolaymat A, al-Mousily F, Sleasman J, Paryani S, Neiberger R. Hyponatremia in pediatric patients with HIV-1 infection. South Med J. 1995;88(10):1039-1042.
7. Miller M, Morley JE, Rubenstein LZ. Hyponatremia in a nursing home population. J Am Geriatr Soc. 1995;43(12):1410-1413.
8. Brophy JM, Deslauriers G, Rouleau JL. Long-term prognosis of patients presenting to the emergency room with decompensated congestive heart failure. Can J Cardiol. 1994;10(5):543-547.
9. Callewart CC, Minchew JT, Kanim LE, et al. Hyponatremia and syndrome of inappropriate antidiuretic hormone secretion in adult spinal surgery. Spine. 1994;19(15):1674-1679.
10. Cusano AJ, Thies HL, Siegal FP, Dreisbach AW, Maesaka JK. Hyponatremia
11. in patients with acquired immune deficiency syndrome. J Acquir Immune Defic Syndr 1990;3(10):949-953.
12. Dhawan A, Narang A, Singhi S. Hyponatraemia and the inappropriate DH syndrome in pneumonia. Ann Trop Paediatr. 1992;12(4):455- 462.
13. Ferreira da Cunha D, Pontes Monteiro J, Modesto dos Santos V, Araujo Oliveira F, Freire de Carvalho da Cunha S. Hyponatremia in acute-phase response syndrome patients in general surgical wards. Am J Nephrol. 2000;20(1):37-41.
14. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA. 2003;290(19):2581-2587.
15. Almond CS, Shin AY, Fortescue EB, et al. Hyponatremia among runners in the Boston Marathon. N Engl J Med. 2005;352(15):1550-1556.
16. Noakes TD, Sharwood K, Speedy D, et al. Three independent biological mechanisms cause exercise-associated hyponatremia: evidence from 2,135 weighed competitive athletic performances. Proc Natl Acad Sci U S A. 2005;102(51):18550-18555.
17. Noakes T. Fluid replacement during marathon running. Clin J Sport Med. 2003;13(5):309-318.
18. Schrier RW, Chen YC, Cadnapaphornchai MA. From finch to fish to man: role of aquaporins in body fluid and brain water regulation. Neuroscience. 2004;129(4):897-904.
19. Kokko JP, Rector FC Jr. Countercurrent multiplication system without active transport in inner medulla. Kidney Int. 1972;2(4):214-223.
20. Schrier RW, Cadnapaphornchai MA, Umenishi F. Water-losing and water-retaining states: role of water channels and vasopressin receptor antagonists. Heart Dis. 2001;3(3):210-214.
21. Schrier RW, Goldberg JP. The physiology of vasopressin release and the pathogenesis of impaired water excretion in adrenal, thyroid, and edematous disorders. Yale J Biol Med. 1980;53(6):525-541.
22. Schrier RW, Berl T, Anderson RJ. Osmotic and nonosmotic control of vasopressin release. Am J Physiol. 1979;236(4):F321-F332.
23. Kim JK, Summer SN, Wood WM, Schrier RW. Role of glucocorticoid hormones in arginine vasopressin gene regulation. Biochem Biophys Res Commun. 2001;289(5):1252-1256.
24. Kim JK, Summer SN, Schrier RW. Effect of kappa opioid agonist RU 51599 on osmotic and non-osmotic stimulated arginine vasopressin release and gene regulation in small cell lung carcinoma cells. Neuropeptides. 1997;31(5):423-429.
25. Xu DL, Martin PY, St John J, et al. Upregulation of endothelial and neuronal constitutive nitric oxide synthase in pregnant rats. Am J Physiol. 1996;271(6 Pt 2):R1739-R1745.
26. Pyo HJ, Summer SN, Niederberger M, Kim JK, Schrier RW. Arginine vasopressin gene expression in rats with puromycin-induced nephritic syndrome. Am J Kidney Dis. 1995;25(1):58-62.
27. Soni BM, Vaidyanthan S, Watt JW, Krishnan KR. A retrospective study of hyponatremia in tetraplegic/paraplegic patients with a review of the literature. Paraplegia. 1994;32(9):597-607.
28. McGirt MJ, Blessing R, Nimjee SM, et al. Correlation of serum brain natriuretic peptide with hyponatremia and delayed ischemic neurological deficits after subarachnoid hemorrhage. Neurosurgery 2004;54(6):1369-73; discussion 1373-1374.
29. Liamis GL, Milionis HJ, Rizos EC, Siamopoulos KC, Elisaf MS. Mechanisms of hyponatraemia in alcohol patients. Alcohol Alcohol 2000;35(6):612-616.
30. Thaler SM, Teitelbaum I, Berl T. “Beer potomania” in non-beer drinkers: effect of low dietary solute intake. Am J Kidney Dis. 1998; 31(6):1028-1031.
31. Siegel AJ, Verbalis JG, Clement S, et al. Hyponatremia in marathon runners due to inappropriate arginine vasopressin secretion. Am J Med. 2007;120:461.e11-461.e17.
32. Gowrishankar M, Lin SH, Mallie JP, Oh MS, Halperin ML. Acute hyponatremia in the perioperative period: insights into its pathophysiology and recommendations for management. Clin Nephrol. 1998; 50(6):352-360.
33. Arieff AI. Hyponatremia, convulsions, respiratory arrest, and permanent brain damage after elective surgery in healthy women. N Eng  J Med. 1986;314(24):1529-1535.
34. Ayus JC, Wheeler JM, Arieff AI. Postoperative hyponatremic encephalopathy in menstruant women. Ann Intern Med. 1992;117(11):891-897.
35. Ayus JC, Arieff A, Moritz ML. Hyponatremia in marathon runners.N Engl J Med. 2005;353(4):427-8; author reply 427-428.
36. Davis DP, Videen JS, Marino A, et al. Exercise-associated hyponatremiain marathon runners: a two-year experience. J Emerg Med. 2001;21:47-57.
37. Fraser CL, Arieff AI. Epidemiology, pathophysiology, and management of hyponatremic encephalopathy. Am J Med. 1997;102(1):67-77.
38. Arieff AI, Kozniewska E, Roberts TP, Vexler ZS, Ayus JC, Kucharczyk J. Age, gender, and vasopressin affect survival and brain adaptation in rats with metabolic encephalopathy. Am J Physiol. 1995; 268(5 Pt 2):R1143-R1152.
39. Fraser CL, Swanson RA. Female sex hormones inhibit volume regulation in rat brain astrocyte culture. Am J Physiol. 1994;267(4 Pt 1):C909-C914.
40. Lien YH, Shapiro JI, Chan L. Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia. Implications for the pathogenesis of central pontine myelinolysis. J Clin Invest. 1991;88(1):303-309.
41. Adams RD, Victor M, Mancall EL. Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients. AMA Arch Neurol Psychiatry. 1959;81(2):154-172.
42. Wright DG, Laureno R, Victor M. Pontine and extrapontine myelinolysis. Brain. 1979;102(2):361-385.
43. Kleinschmidt-DeMasters BK, Norenberg MD. Rapid correction of hyponatremia causes demyelination: relation to central pontine myelinolysis. Science. 1981;211(4486):1068-1070.
44. Norenberg MD, Leslie KO, Robertson AS. Association between rise in serum sodium and central pontine myelinolysis. Ann Neurol. 1982;11(2):128-135.
45. Yancey PH, Clark ME, Hand SC, Bowlus RD, Somero GN. Living with water stress: evolution of osmolyte systems. Science.1982;217(4566):1214-1222.
46. Lien YH. Role of organic osmolytes in myelinolysis. A topographic study in rats after rapid correction of hyponatremia. J Clin Invest.1995;95(4):1579-1586.
47. Kokko JP. Symptomatic hyponatremia with hypoxia is a medical emergency. Kidney Int. 2006;69(8):1291-1293.
48. Lauriat SM, Berl T. The hyponatremic patient: practical focus on therapy. J Am Soc Nephrol. 1997;8(10):1599-1607.
49. Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med. 2000;342(21):1581-1589. Nguyen MK, Kurtz I. Analysis of current formulas used for treatment of the dysnatremias. Clin Exp Nephrol. 2004;8(1):12-16.
50. Ghali JK, Koren MJ, Taylor JR, et al. Efficacy and safety of oral conivaptan: a V1A/V2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia. J Clin Endocrinol Metab. 2006;91(6):2145-2152.



Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2023